A study of 153 melanoma and sarcoma patients undergoing immune checkpoint blockade (ICB) therapy has revealed a correlation between social vulnerability and gut microbiome composition, but not with overall survival, researchers reported this week. The findings, published in AJMC, suggest that while disadvantaged social circumstances are linked to less diverse and potentially less beneficial gut […]
You can read the full story here: Gut Microbiome & ICB Response: Social Factors, Melanoma & Sarcoma .